Suppr超能文献

基于强效纳米反应介体的铁死亡策略逆转索拉非尼的肿瘤化疗耐药性。

Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.

机构信息

Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), School of Physical and Mathematical Sciences, Nanjing Tech University (NanjingTech), Nanjing 211816, China.

Department of Pharmaceutics, School of Pharmacy, Nanjing Medical University, Nanjing 210009, China.

出版信息

Acta Biomater. 2023 Mar 15;159:237-246. doi: 10.1016/j.actbio.2023.01.053. Epub 2023 Feb 1.

Abstract

The drug resistance of cancer cells is related to a variety of mechanisms, among which the destruction of redox homeostasis is one of the key factors. Ferroptosis, an intracellular iron-dependent form of cell death, is related to the production of oxidative stress. The accumulation of lipid peroxidation (LPO) during ferroptosis disrupts intracellular redox homeostasis, thereby affecting the sensitivity of tumor cells to drugs. In this work, we proposed a ferroptosis strategy based on LPO accumulation, reduced glutathione generation via inhibition of SLC3A2 protein and inactivated glutathione peroxidase 4 (GPX4) to reverse the chemoresistance of cancer cells. The Fenton reaction based on the ferroptosis-inducing nanoreactors (Au/Fe-GA/Sorafenib@PEG) not only generated hydroxyl radicals (·OH) under laser irradiation to realize the accumulation of LPO, but also depleted GSH to increase the accumulation of LPO. Meanwhile, the cystine uptake of cells was inhibited by Sorafenib, resulting in reduced GSH synthesis and inactivated GPX4. In vitro and in vivo experiments demonstrated AFG/SFB@PEG + Laser group could inactivate GPX4 and the enhanced ferroptosis can reverse chemo-resistance caused by continuous upregulation of GPX4 levels in cells through 'self-rescue'. The study proposed the mechanism and feasibility of ferroptosis to reverse drug resistance, providing a promising strategy for chemo-resistant cancer treatment. STATEMENT OF SIGNIFICANCE: Herein, we proposed a ferroptosis strategy based on LPO accumulation, reduced glutathione generation via inhibition of SLC3A2 protein, and inactivated glutathione peroxidase 4 (GPX4) to reverse chemoresistance of cancer cells. The Fenton reaction based on the ferroptosis-inducing nanoreactors (Au/Fe-GA/Sorafenib@PEG) not only generated hydroxyl radicals (·OH) under laser irradiation to realize the accumulation of LPO but also depleted GSH to increase the accumulation of LPO. Meanwhile, the cystine uptake of cells was inhibited by Sorafenib, resulting in reduced GSH synthesis and inactivated GPX4. In vitro and in vivo experiments demonstrated AFG/SFB@PEG + Laser group could inactivate GPX4 and the enhanced ferroptosis can reverse chemo-resistance caused by continuous upregulation of GPX4 levels in cells through 'self-rescue'.

摘要

癌细胞的耐药性与多种机制有关,其中破坏氧化还原稳态是关键因素之一。铁死亡是一种细胞内铁依赖性的死亡形式,与氧化应激的产生有关。铁死亡过程中脂质过氧化(LPO)的积累破坏了细胞内的氧化还原稳态,从而影响肿瘤细胞对药物的敏感性。在这项工作中,我们提出了一种基于 LPO 积累的铁死亡策略,通过抑制 SLC3A2 蛋白和失活谷胱甘肽过氧化物酶 4(GPX4)生成还原型谷胱甘肽来逆转癌细胞的化疗耐药性。基于铁死亡诱导纳米反应器(Au/Fe-GA/Sorafenib@PEG)的芬顿反应不仅在激光照射下产生羟基自由基(·OH)以实现 LPO 的积累,还耗竭 GSH 以增加 LPO 的积累。同时,Sorafenib 抑制细胞胱氨酸摄取,导致 GSH 合成减少和 GPX4 失活。体外和体内实验表明,AFG/SFB@PEG+激光组可通过“自我拯救”失活 GPX4,增强铁死亡可逆转细胞中 GPX4 水平持续上调引起的化疗耐药性。该研究提出了铁死亡逆转耐药性的机制和可行性,为化疗耐药性癌症治疗提供了一种有前途的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验